← Eichor
Study identifier: NCT06892028 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

EEG-based Personalized Transcranial Magnetic Stimulation (eTMS) to Treat Post-Traumatic Stress Disorder

Condition: Stress Disorder, Post Traumatic  ·  Sponsor: Wave Neuroscience

PhaseNA
Planned participants110
Who can joinAll sexes, 22 Years to 65 Years
Healthy volunteersNo

About this study

This is a randomized, sham controlled study of the Electroencephalogram (EEG) based Transcranial Magnetic Stimulation (eTMS) treatment for Post-Traumatic Stress Disorder (PTSD). The recruitment goal is 110 participants who are United States Military veterans or first responders (e.g., firefighters, police, paramedics, etc.). The Study includes an EEG recording in order to determine the optimal treatment parameters for the eTMS system, followed by 15 in-office visits that take place over 21-28 total days. Two eTMS treatment sessions are administered during each office visit.

This description comes directly from the study's public registry record.

Talk to the study team

Matthew Sherwood, PhD  ·  937-775-2342  ·  msherwood@etmsfda.com

Walter Mysiw, MD  ·  614-293-3433  ·  coordinator@etmsfda.com

Always discuss trial participation with your own doctor first.

Locations (2)

Wright State UniversityDayton, Ohio, United StatesRecruiting
D2 Human Performance CenterPickerington, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06892028